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1 
Abstract 
Consumption of kombucha has been shown to promote human gut health and act as an 
antibacterial agent against enteric pathogens. This thesis investigates if kombucha consumption changes 
the composition of the human gut microbiota and aims to measure its inhibitory effects on the growth 
of an enteric pathogen, Salmonella typhimurium. We predicted consumption of kombucha will alter the 
composition of the gut microbiota and demonstrate antibacterial activity in the presence of S. 
typhimurium. Research suggested that alterations in the gut microbiota is associated with multiple 
chronic diseases. It is further noted that kombucha and other probiotics may be used to restore proper 
gut health. Based on the literature, we suggest that kombucha has an effect on gut health. To test its 
antibacterial activity, a Kirby-Bauer Disc Diffusion Assay was performed. Kombucha’s zone of inhibition 
for S. typhimurium was compared to two antibiotics (ampicillin, ciprofloxacin) on TSA agar. Both 
antibiotics displayed consistent inhibitory effects, however, kombucha did not inhibit S. typhimurium 
growth. While kombucha and other probiotics affect the composition of the gut microbiota, kombucha 
did not demonstrate antibacterial activity against S. typhimurium. 
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Introduction 
Fermentation: 
 Microbial fermentation is a metabolic process performed by microorganisms that convert sugars 
into acids, alcohol, or gases (Lumen, 2020). This type of metabolic process occurs when microorganisms 
lack sufficient amounts of inorganic final electron acceptors or do not have genes responsible for fueling 
the Krebs cycle and electron transport chain (Lumen, 2020). Fermentation readily occurs when 
microorganisms encounter susceptible substrates that can be used as a fuel source for various metabolic 
systems (Hasan, Sultan, & Mar-E-Um, 2014). These metabolic interactions within the microorganism’s 
environment include the decomposition of natural materials, which returns chemical elements back to 
the source, and creates fermented food and beverage products (Hasan, Sultan, & Mar-E-Um, 2014). 
Microbial fermentation has been extensively researched and utilized to produce vitamins, 
alcohol, fermented foods, and fermented beverages (Bisen, 2014). Thus, microbial fermentation 
provides various benefits to society. For example, fermented foods have demonstrated a multitude of 
positive effects on the human body and are known to increase food nutritional quality through three 
main mechanisms. First, fermented foods contain microorganisms that contain anabolic properties 
allowing it to synthesize vitamins that unfermented food do not have. Secondly, fermentation breaks 
down indigestible structures, in certain grains and seeds for example, which allows the release of 
nutritional carbohydrates and proteins. The last mechanism that fermentation is known for is increasing 
food's nutritional value. Microorganisms have the ability to split indigestible complex sugars into simple 
sugar, which eases the digestion of foods in the human body (Hasan, Sultan, & Mar-E-Um, 2014). In 
addition to fermented foods, microbial fermentation can also be applied to the field of medicine by 
aiding in the creation of antibiotics, such as penicillin and tetracycline (Bisen, 2014).  
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In terms of fermentation, there are two major types performed by microorganisms: lactic acid 
fermentation and alcoholic fermentation (Lumen, 2020). Lactic acid fermentation is the chemical 
conversion of pyruvate and NADH into lactic acid and NAD+. This type of fermentation can be used to 
make fermented vegetables (sauerkraut), sourdough bread, fermented milks (yogurts and cheeses), as 
well as protein-rich vegetable meat substitutes (National Academy Press, 1992). In comparison, alcoholic 
fermentation converts sugars to ethanol, carbon dioxide, and other metabolic byproducts. This 
biological conversion can produce a variety of consumable products such as wine, beer, spirits, vinegar, 
and kombucha (ScienceDirect, 2017). 
 
Probiotics: 
Probiotics are living microbial organisms which when administered in adequate amounts can 
provide health benefits for the host (Hegazy & Bedewy, 2010). Common foods that contain probiotics 
are yogurt, fermented/unfermented milk, tempeh, juices, and other beverages like kombucha 
(Kozyrovska et al., 2012). Bifidobacteria and Lactobacilli are two probiotics that are generally found in 
consumable foods and beverages (Hegazy & Bedewy, 2010). Humans tend to consume probiotics 
because of the extensive health outcomes they have on the internal environment such as aiding in 
digestion, improving the immune system, and detoxifying the body (Kozyrovska et al., 2012). A 
commercialized probiotic, Lactobacillus rhamnosus HN001, has proven to be beneficial in women's 
medicine, specifically relating to vaginal and postpartum health (Cheng et al., 2019). Prior research 
suggests that probiotics can be used to treat a variety of diseases, including liver disease, hypertension, 
allergies, mental health impairments, and reduce sepsis mortality (Cheng et al., 2019). While there are 
clear benefits to consuming probiotics in regard to combating certain diseases and promoting overall 
health, the mechanisms by which probiotics carry out these activities are still of question (Hasan, Sultan, 
& Mar-E-Um, 2014). Hasan, Sultan, & Mar-E-Um (2014) suggest that probiotics modify the pH of the gut, 
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stimulate immunomodulatory cells, inhibit pathogens through antibacterial compounds, and 
outcompete pathogens by binding to their receptor sites. In light of the recent findings, it is critical to 
investigate the properties of probiotics and how certain probiotics, like kombucha, impacts human 
health and overall the field of medicine. 
 
Kombucha: 
 Kombucha is a probiotic beverage that originates from the fermentation of tea leaves leading to 
the production of a symbiotic microbial community consisting of acetic bacteria and yeasts (Kozyrovska 
et al., 2012; Kaewkod, Bovonsombut, & Tragoolpua, 2019). While bacteria and yeast live in community 
in kombucha, it is important to note that they are each responsible for different metabolic pathways 
that serve the beverage (Kaewkod, Bovonsombut, & Tragoolpua, 2019). Tea leaves undergo 
fermentation in a sugar-rich environment and yeast cells break down sucrose to glucose (Kaewkod, 
Bovonsombut, & Tragoolpua, 2019). Ethanol is produced from fermentation, which is a critical step 
because acetic bacteria relies on ethanol to produce cellulose fiber and organic acids, and this 
production of acids leads to a drop in the pH value of kombucha during fermentation (Kozyrovska et al., 
2012; Kaewkod, Bovonsombut, & Tragoolpua, 2019). These conversions form a cellulose mat, which is 
formally known as the symbiotic culture of bacteria and yeast (SCOBY). Both ethanol and organic acid 
products serve to protect the SCOBY by inhibiting other microbes from colonizing (Kozyrovska et al., 
2012). The bacteria typically found in probiotics are from the Lactobacillus and Bifidobacterium genus, 
while Saccharomyces boulardii and S. cerevisiae are common yeasts that are stated to be probiotics 
(Kozyrovska et al., 2012). Kombucha has gathered attention in the scientific community because of the 
metabolites the SCOBY produces, and its suggested positive health effects (Kozyrovska et al., 2012). The 
SCOBY’s metabolites have been known to promote gastrointestinal health, and more recently it has 
been documented to demonstrate antimicrobial activity (Kozyrovska et al., 2012). Of interest in this 
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thesis is how kombucha affects the composition of the human gut microbiota and further exploring its 
antimicrobial properties against pathogens.  
 
Kombucha and the human gut microbiota: 
The term “microbiome” refers to the functional collection of microbes and their genetic material 
in a particular environmental system, such as the human body (Lu & Liu, 2016). A “microbiota” describes 
all the microbes in a microhabitat or a specific area of the microbiome. Each human harbors a 
substantial number of microbial cells, inside and outside of the body. In total, the human microbiome 
consists of 10 to 100 trillion symbiotic microorganisms (Ursell et al., 2012). When analyzing the human 
microbiome, most microbial cells are found in the mouth and gut, and on the skin (Lloyd-Price, Abu-Ali, 
& Huttenhower, 2016). The most sterile areas of the human microbiome are the blood and brain, due to 
the blood brain barrier, and research notes the lungs may have sterility as well (Lloyd-Price, Abu-Ali, & 
Huttenhower, 2016). 
A specific area of the human microbiome, the gut microbiota, plays a critical role in the body's 
overall health (Kozyrovka et al., 2012; Singh et. al, 2017). It is known that the human gut microbiota has 10!" residential microorganisms and 5,000 species of facultative and strict anaerobes that aid in 
maintaining internal balance for the human host (Kozyrovka et al., 2012; Singh et. al, 2017). These 
microorganisms include bacteria, viruses, fungi, and protozoa. In the intestinal microbiota, 
Actinobacteria, Firmicutes, Bacteroidetes, Fusobacteria, and Proteobacteria, are the five types of 
bacteria that are most often identified, with Firmicutes and Bacteroidetes being the most prevalent 
(Kozyrovka et al., 2012; Singh et. al, 2017). 
The microbial cells in the gut perform a variety of functions for humans. These include 
synthesizing vitamins, generating metabolic byproducts for energy usage, and promoting immunity 
(Singh et al., 2017). The gut microbiota also functions to gather energy from our diet, stimulate 
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epithelial growth, regulate fat storage, and develop the immune system (Kozyrovska et al., 2012). 
Therefore, it is important to consider the factors that alter the gut microbiota's bacterial makeup 
because it can alter the overall health and disease state of an individual. A person’s diet, antibiotic 
usage, age, genotype, and other factors (Fig. 1) play a large role in changing the composition of the gut 
microbiota (Hasan & Yang, 2019; Kozyrovska et al., 2012). Due to the critical role the gut microbiota 
plays in creating a healthy environment in the human body, it is of interest to study the mechanisms 
that could potentially alter the gut microbiota. Microbial modifications in the gut have been shown to 
have both negative and positive impacts, making it an area of research that is important to understand 
(Singh et al., 2017).  
A change in the gut microbiota has been associated with numerous chronic diseases, such as 
obesity, type 1 diabetes, non-alcoholic fatty liver disease (NAFLD), hypertension, multiple sclerosis, 
irritable bowel disorder, and gastrointestinal cancers (Jung et al., 2018; Kozyrovska et al., 2012). 
Additionally, the overgrowth of Clostridium difficile, Proteus spp., and B. fragilis, which are intestinal 
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pathogens, can lead to severe functional disorders (Kozyrovska et al., 2012). Prior research 
demonstrates that kombucha has healing-like properties on the composition of the gut microbiota in 
mice with NAFLD. The study found that kombucha decreased the bacteria in the mice’s gut that 
contributed to the progression of NAFLD (Jung et al., 2018). Could the consumption of kombucha reduce 
the progression of other chronic diseases by beneficially altering the gut microbiota? Based on a primary 
literature review, we hypothesized that kombucha will beneficially alter the composition of the human 
gut microbiota, and kombucha consumption can be associated with various chronic disease states. 
 
Kombucha’s antibacterial properties: 
Bacterial infections among the human population is commonly treated with antibiotics, which 
have the ability to kill (bactericidal) or inhibit (bacteriostatic) pathogen growth. However, many bacteria 
have developed specific properties that resist the antibiotic’s mechanism of action. In the scientific and 
medical communities, these strains of bacteria are considered antibiotic resistant (Mayo Clinic, 2020). 
The Mayo Clinic (2020) explains that while many variables contribute to the emergence of antibiotic 
resistance, high prescription dosages and wrongful prescription of antibiotics are major factors. Because 
antibiotic resistance has become a prominent issue in medicine, researchers have placed an emphasis 
on finding alternative antibacterials in hopes to decrease the use of antibiotics. Battacharya et al. (2016) 
investigated the antibacterial potential of the traditional beverage, kombucha, to fight bacterial 
infections, which raises the question: can alternative antibacterial products, like kombucha, be 
consumed as a method to combat the evolving problem of antibiotic resistance? 
Before answering this question, it is important to understand what properties of kombucha may 
aid in its antibacterial activity. Previous research demonstrates that kombucha has antibacterial 
properties against various enteric pathogens, such as E. coli, Shigella dysenteriae, S. typhimurium and 
Vibrio cholera (Kaewkod, Bovonsombut, & Tragoolpua, 2019). This study concluded that the presence of 
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organic acids in kombucha was positively correlated with antibacterial activity, and thus contributed to 
its inhibitory effect on bacterial growth. However, Sreeramulu, Zhu, and Knol (2000) tested kombucha at 
a neutral pH and found similar antibacterial activity against pathogenic microbes suggesting there are 
other compounds that contribute to kombucha's inhibitory properties. Bhattacharya et al. (2016) points 
to kombucha’s polyphenolic content as a main contributor to its bactericidal activity rather than organic 
acids. Polyphenols are chemicals found in plant-based foods and are primarily known for their 
antioxidant activity (Sign et al., 2017). This study identified catechin and isorhamnetin in its polyphenolic 
fraction and concluded it has potent effects against enteric pathogens, suggesting polyphenols offer 
other health benefits (Bhattacharya et al., 2016). 
Fermentation time and the type of tea leaves also affect its antibacterial activity. Bhattarcharya 
et al. (2016) fermented kombucha samples for 0, 7, 14 and 21 days before measuring its antibacterial 
activity against various enteric pathogen strains such as, E. coli O157:H7, Vibrio cholerae N16961, 
Shigella flexneri 2a 2457T, and S. typhimurium NCT 572. Their results state that without fermentation, 
kombucha had weak inhibitory effects. Kombucha that was allowed to ferment for one week inhibited 
the growth of all bacteria strains except S. Typhimurium (Bhattarcharya et al., 2016). However, the 
samples that fermented for 14 and 21 days demonstrated equal bacteriostatic and bactericidal activity 
against all strains of bacteria, except S. Typhimurium (Bhattacharya et al., 2016). Although S. 
Typhimurium was more susceptible to 21-day fermented kombucha, resulting in a greater zone of 
inhibition, Bhattarcharya et al. (2016) determined the 14-day kombucha had maximum inhibitory 
activity. Furthermore, Battikh et al. (2012) found that kombucha fermented from green tea had a larger 
zone of inhibition against S. Typhimuriuma than black tea. However, it is important to preface that a 
similar study was conducted recently by Kaewkod, Bovonsombut, & Tragoolpua (2019), which concluded 
that the type of tea leaf, whether it was green, black, or oolong, did not alter kombucha’s inhibition 
against enteric pathogens. 
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It is clear that further research should be conducted to better understand what properties of 
kombucha create its antibiotic-like effects. While this question is important, the aim of the current study 
is to investigate if kombucha can be used in substitute of an antibiotic to treat an enteric strain of S. 
typhimurium. We hypothesized that kombucha would demonstrate antibacterial activity in the presence 
of S. typhimurium, and thus potentially replacing the common treatment of antibiotics.   
 
Methods 
Bacteria isolation: 
S. typhimurium (ATCC 13311) was used as the enteric pathogen in the current study. S. 
typhimurium was inoculated from a frozen stock culture into sterile trypticase soy broth (TSB) and 
grown overnight at 37°C. The overnight culture was used to streak for isolation to ensure that a pure 
culture was being used to create the bacterial lawns of S. typhimurium.  
 
Kombucha type and fermentation process: 
 One bottle of Deane’s Kombucha, Strawberry Lemon flavor, was used for the entirety of this 
experiment. Deane’s kombucha undergoes a continuous brew in 30-gallon oak barrels. Once a mature 
culture is formed, the SCOBY is added to the oak barrel and fermented for seven days. After seven days, 
20 gallons is taken out of the original barrel to be infused with whole, organic fruit for three days. The 
remaining ten gallons are used as the SCOBY for following brews. After the fruit has been infused, 
fermentation continues in anaerobic conditions for four to seven more days. For purposes of this 
experiment, total fermentation time was 14 days (Deane’s Kombucha, personal communication, Feb. 13, 
2020). 
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Kirby-Bauer disc diffusion assay: 
Kirby-Bauer disc diffusion assay was used to test the inhibitory effects of kombucha (Deane’s 
Kombucha: Strawberry Lemon flavor), two antibiotics [Ampicillin (AMP, 10 µg) and Ciprofloxacin (CIP, 5 
µg)], and a control. This disc diffusion assay procedure has been previously described by Traub & 
Leonhard (1994). AMP10 and CIP5 were placed in the center of the bacterial lawn. Whereas 
experimental discs were soaked in kombucha for two minutes, control discs were soaked in water for 
two minutes, and were then placed on the bacterial lawn. All plates were incubated at 37°C for 28 hours 
and zones of inhibition were measured in millimeters (mm). A total of seven trials were used for the 
experimental groups (kombucha, AMP10, CIP5), and three trials were used for the control. 
 
Statistical analysis: 
         To determine if the inhibitory effects of kombucha, AMP10, and CIP5 were significant, GraphPad 
Prism Scientific Software was used for statistical analysis (Motulsky et al., 2020). We computed p-values 
to determine significance using the one-way ANOVA function in GraphPad. Two kinds of comparisons 
were performed. First, to determine overall significance the mean of all inhibitory zones was analyzed. 
Following this, we completed a Tukey multiple comparison between kombucha, AMP10, and CIP5 to 
compare their antibacterial effects against S. typhimurium. 
 
 
 
 
11 
Results 
Kombucha’s effect on the composition of the gut microbiota: 
In terms of relative bacterial abundance, MCD-fed (methionine-choline deficient) and MCD+KT 
(MCD-fed and kombucha tea) experimental groups were associated with an alteration in the 
composition of the gut microbiota compared to control groups. The Erysipelotrichi class (Firmicute 
phylum) were not present in any of the control mice, however, were present in both of the experimental 
groups. MCD-fed mice had a more significant increase in the relative abundance of the Erysipelotrichi 
class when compared to MCD+KT mice. The Bacteroidia class (Bacteroidetes phylum) were most 
abundant in the MCD+KT experimental groups. Furthermore, kombucha paired with the MCD diet led to 
the highest amount of Bacteroidia. Relative abundance of Bacilli (Firmicute phylum) and 
Betaproteobacteria (Proteobacteria phylum) were the highest in control mice, and least abundant in 
MCD-fed mice (Jung et al., 2018). 
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 There was no significant difference between the dominant genera of the MCD or MCD+KT mice. 
Allobaculum and Turicibacter play a role in the pathogenesis of NAFLD and were both significantly 
decreased in the MCD-fed db/db mice after kombucha tea treatment. Also, the Clostridium genus was 
not present in the control mice. Clostridium primarily existed in the MCD-fed mice, and the MCD+KT 
mice were under-represented in the gut microbiota samples. Bacteria from the Lactobacillus genus were 
more abundant in the MCD+KT mice compared to the MCD-fed mice, however, the control mice 
represented the highest relative abundance of Lactobacillus. Additionally, Mucispirillum genus were only 
found in the MCD+KT mice (Jung et al., 2018). 
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Kombucha and its application to disease: 
 
 
Based on histomorphology images of hepatocytes, the consumption of kombucha tea leads to 
the reduction in fat accumulation surrounding the liver in mice with NAFLD. Image(s) of hepatocytes 
represent that MCD-fed mice had excessive macrovesicular and microvesicular fat compared to the 
normal-fed and kombucha-treated mice. Kombucha tea consumption for MCD-fed mice served to 
display a lipoprotective effect on the liver (Jung et al., 2018). 
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 Kombucha tea and black tea consumption decreases the enzyme activity of α-amylase in the 
plasma and pancreas and improves elevated blood glucose conditions of diabetic rats. The control group 
rats endured significant increases of blood glucose concentrations, and α-amylase activities in the 
plasma [(405 +/- 53%), (p<0.05)] and pancreas [(225 +/- 52%), (p<0.05)]. Consumption of kombucha tea 
in diabetic rats has a greater inhibitory effect on α-amylase activities in the plasma and pancreas than 
black tea. Furthermore, kombucha tea significantly suppresses hyperglycemic conditions more 
effectively compared to black tea. More specifically, kombucha tea supplementation brought about a 
significant decrease of 50 +/- 11% (p < 0.05) when referring to its effect on blood glucose concentration 
(Aloulou et al., 2012). 
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Kombucha’s antibacterial properties: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zone of inhibition were measured for the antibiotic and kombucha soaked discs that were 
placed on the bacterial lawns. The asterisks above the brackets represent the level of p-value 
significance (*** p<0.001) (Fig. 5). Abundant S. typhimurium growth was present on all TSA agar plates 
after 28 hours of incubation time. An ordinary one-way analysis of variance (ANOVA) results suggested 
that there was overall statistical significance (p<0.001). Multiple comparisons were used to further 
analyze the data by separating the antibiotics and kombucha. While both antibiotics, AMP10 and CIP5, 
demonstrated inhibitory activity against the enteric pathogen, CIP5 had a larger mean zone of inhibition 
(32.6 mm) which was significantly larger (p<0.001) than AMP10’s mean zone of inhibition (23.7 mm). 
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The kombucha soaked discs did not suppress the growth of S. typhimurium, which is represented as a 
mean zone of inhibition of zero, similar to the control. Both antibiotics had inhibitory zones that were 
statistically larger than kombucha-treated samples. 
 
Discussion 
 
 In the current study, we conducted a literature review on how kombucha affects the gut 
microbiota and completed an experiment to determine if kombucha’s antibacterial properties would 
demonstrate successful inhibition against S. typhimurium. In regard to the gut microbiota, our prediction 
that kombucha would alter the gut was supported and kombucha consumption can help manage certain 
chronic diseases. In regard to the laboratory experiment which analyzed kombucha’s antibacterial 
capacity, we originally predicted that kombucha would inhibit the growth of S. typhimurium due to its 
said antibacterial properties. However, this prediction was not supported by the data collected from the 
Kirby-Bauer disc diffusion assay. 
 
Kombucha’s effect on the composition of the gut microbiota and its application to 
disease: 
 It is widely known in scientific research that imbalances in the gut microbiota contribute to 
disease (Hasan & Yang, 2019). Because of this knowledge, many have researched what causes 
disturbances in the gut in hopes to prevent these agents from generating human disease. Scientific 
literature has expressed that our diet may be a contributing factor to alterations in gut health (Hasan & 
Yang, 2019; Singh et al., 2017). Furthermore, Kozyrovska et al. (2012) and Singh et al. (2017) state that 
probiotic microorganisms help balance the intestinal microbiota. With that being considered, it seems to 
be known that understanding how diet affects gut health is important because of its association to 
disease. With that being considered, based on the literature review, it is evident that kombucha affects 
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the composition of the gut microbiota, and can improve various chronic disease states, such as NAFLD 
and diabetes (Aloulou et al., 2012; Jung et al., 2018; Kozyrovska et al., 2012). 
 The study conducted by Jung et al. (2018) demonstrates the beneficial applications that 
kombucha has against NAFLD. Twelve eight-week old mice were split into three different dietary groups. 
Four mice received a normal diet and water (control), while the other eight mice consumed a 
methionine/choline-deficient (MCD) diet. While all eight of the MCD-fed mice drank water, half of the 
mice were administered 2g/kg of kombucha powder which was dissolved in their water. It is important 
to mention that MCD diets result in liver injury and are commonly used in research to induce non-
alcoholic steatohepatitis (NASH), which is a more progressive form of NAFLD (Machado et al., 2015). 
As depicted in Fig. 4, the consumption of kombucha tea led to the reduction in fat accumulation 
surrounding the liver and serves to produce a lipoprotective effect on the liver (Hyun et al., 2016). The 
MCD-fed mice without the administration of kombucha had more severe steatosis with increased fat 
droplets when compared to MCD+KT mice (Jung et al., 2018). Additionally, in relation to the 
composition of the gut microbiota, Jung et al. (2018) noted that both the control and MCD-fed mice 
demonstrated a 1:1 ratio of Firmicutes to Bacteroidetes. However, it is important to mention that 
patients with NASH have a lower level of Bacteroidetes, meanwhile it was found that in MCD+KT mice, 
Bacteroidetes in the intestinal microbiota increased (Fig. 2; Jung et al., 2018). This signifies that 
kombucha was able to alter the composition of the gut microbiota by increasing the relative abundance 
of Bacteroidetes. This compositional change decreases the 1:1 ratio of Firmicutes to Bacteroidetes, and 
thus serves as a protective mechanism against NAFLD. While this is an interesting finding, causal claims 
cannot be made, and this ratio alteration may only be a correlational finding. 
Furthermore, Allobaculum and Turicibacter, which are dominant bacteria that contribute to the 
progression of NAFLD, were decreased in the MCD+KT mice (Jung et al., 2018). Kombucha alters the gut 
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microbiota by lowering the amounts of Allobaculum and Turicibacter in the gut, as seen in the MCD+KT 
mice. While this provides additional evidence that kombucha slows the advancement of NAFLD, the 
mechanism is not understood clearly. It is predicted that the microbial structural or chemical 
components of kombucha tea might contribute to the decreased progression of NAFLD (Jung et al., 
2018). 
It is also emphasized that MCD+KT mice had more Lactobacillus present in their gut than MCD-
fed mice. This is of particular significance because this genus of bacteria has several protective effects 
that work against the pathogenesis of NAFLD (Jung et al., 2018). Another alteration that occurred in the 
intestinal microbiota of the MCD+KT mice was a presence of Mucispirillum genus (Fig. 3; Jung et al., 
2018). Previous studies explain that there is a positive correlation between Mucispirillum and the 
hormone, leptin (Ravussin et al., 2012). This is advantageous because leptin acts on the brain to 
suppress hunger which will decrease food intake and body fat while increasing metabolic activity 
(Brennan & Mantzoros, 2006). Although this correlation isn’t directly related to NAFLD, the increase in 
Mucispirillum (due to kombucha consumption) may lead to an improved overall health-status and a 
decrease in body fat. 
 The consumption of kombucha can also improve hyperglycemia in diabetic subjects. In 
comparison to black tea, kombucha produces a higher inhibitory effect of α-amylase in the plasma and 
pancreas of alloxan diabetic rats. Alloxan is a toxin which creates excess reactive oxygen species that 
damages pancreatic beta cells and inhibits insulin production in response to glucose in the blood 
(Aloulou et al., 2012). The key digestive enzyme, α-amylase, hydrolyses alpha bonds of starches, which 
yields maltose and glucose molecules (Aloulou et al., 2012). As the activity of α-amylase increases, blood 
glucose levels will also increase, and this can lead to hyperglycemic conditions. However, kombucha 
consumption significantly inhibits the activity of α-amylase, decreasing its ability to break down and 
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absorb glucose, which prevents the rat from entering hyperglycemic conditions (Fig. 5; Aloulou et al., 
2012). While kombucha has a multitude of metabolites that enhance its health benefits, the beverages 
polyphenolic composition contributes most to its antidiabetic properties of reducing α-amylase activity 
in the intestines of rats (Aloulou et al., 2012). 
Before patients start an antidiabetic drug, life-style interventions are initially suggested in 
efforts to control blood glucose without the need of any medication (Chaudhury et al., 2017). Since the 
consumption of kombucha significantly inhibits the activity of α-amylase in alloxan diabetic rats, this 
type of fermented beverage could be incorporated into a patient’s initial life-style intervention plan. The 
integration of this natural-probiotic beverage early on in one’s diabetic diagnosis, may prevent the 
individual from relying on pharmaceuticals to control their blood glucose levels. This premature action 
could also avoid the side effects that many diabetic medications have on the individual. Metformin, the 
best first-line drug therapy for type 2 diabetes, has side effects such as dizziness, muscle pain, difficulty 
breathing, irregular heartbeat, and others (Nasri & Rafieian-Kopaei, 2014). 
 
Analysis of kombucha’s antibacterial properties against S. typhimurium: 
 In the current study, kombucha did not inhibit the growth of S. typhimurium which was 
demonstrated by a zone of inhibition of zero (Fig. 6). However, both CIP5 and AMP10 inhibited the 
growth of S. typhimurium signifying that this strain, derived from S. typhimurium (ATCC 13311), was 
susceptible to these antibiotics. While both antibiotics successfully inhibited growth, CIP5 had a 
significantly larger mean zone of inhibition (32.6 mm) than AMP10 (23.7 mm), which represents S. 
typhimurium was more sensitive to CIP5 (Fig. 6). This is of interest because S. typhimurium has 
demonstrated antibiotic resistance patterns which has raised concerns and limited treatment options to 
fight this enteric infection (Wang et al., 2019). Prior evaluations of antibiotic resistance in 11,447 strains 
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of S. typhimurium suggests that S. typhimurium is most susceptible to fluoroquinolones, meanwhile, S. 
typhimurium displayed high resistance against ampicillin (Wang et al., 2019). The fluoroquinolone 
compound, ciprofloxacin, is recommended to treat Salmonella infections due to its broad-spectrum 
properties (Fàbrega & Vila, 2013). These results coincide with our findings as the plated CIP5 antibiotic 
disc inhibited S. typhimurium growth to a greater degree than AMP5 (Fig. 6). However, AMP5 still 
prevented the growth of S. typhimurium suggesting that although its inhibitory effect was not as 
effective as CIP5, it is not necessarily resistant to S. typhimurium (ATCC 13311) in the current study. 
Understanding which antibiotics have stronger inhibitory mechanisms against S. typhimurium is 
beneficial knowledge for healthcare providers who are looking to treat patients with this enteric 
infection. If it is understood that ciprofloxacin is a better treatment option than ampicillin for S. 
typhimurium infections, the patient will decrease their exposure to multiple antibiotics, helping to 
reduce the occurrence of antibiotic-resistance. 
It was found that kombucha did not inhibit the growth of S. typhimurium, however, this is not 
supported by previous literature. S. typhimurium was found to be sensitive to kombucha at a natural pH 
(without any pH adjustments), neutral pH of 7, and when kombucha was exposed to heat (Sreeramulu, 
Zhu, & Knol, 2000). Additionally, it is highlighted that antimicrobial activity increased with the length of 
fermentation, thus kombucha fermented for a period of 10-14 days, demonstrated maximum zones of 
inhibition (30-35 mm) against S. typhimurium (ATCC 13311) (Sreeramulu, Zhu, & Knol, 2000). Differences 
in our results may be due to the strain of bacteria used in the present study. The strain used was derived 
from S. typhimurium (ATCC 13311) that Saint John’s University has had for many years, so there are 
likely lab adaptations (mutations). The S. typhimurium strain may have mutated and acquired resistant 
mechanisms that are effective against weaker antibacterial products (kombucha beverage used), which 
limits our ability to draw conclusions from these results. Furthermore, it is important to recall that 
Deane’s Kombucha carried out its fermentation process in oak barrels, whereas typical kombucha 
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fermentation is performed in glass brewing vessels (Sreeramulu, Zhu, and Knol, 2000). Future research 
should explore how the type of fermentation vessel affects kombucha’s antibacterial properties. If 
research finds that one type of fermentative vessel produces greater antibacterial properties, then 
suggestions could be made in efforts to have consumers receive the highest health-related benefits, and 
thus be implemented as a useful antibacterial agent. With that being considered, this natural beverage 
may be used as an alternative to antibiotics, helping to decrease resistance around the globe.  
When compared to an antibiotic control, kanamycin, kombucha demonstrated a smaller zone of 
inhibition than the antibiotic (Bhattacharya et al., 2016). However, it was concluded that kombucha 
could be used as an antibacterial agent against enteric pathogens due to its polyphenolic content that 
gives rise to its bactericidal properties (Bhattacharya et al., 2016). While our study does not further 
support this notion, kombucha’s antibacterial properties are still considered cost-effective, accessible, 
and potentially a safer alternative when compared to the prescription of broad-spectrum antibiotics 
(Bhattacharya et al., 2016).  
 
Conclusion 
 Kombucha enhances the composition of the gut microbiota and is applicable to reducing the 
progression of chronic diseases, more specifically, NAFLD and diabetes mellitus. However, the current 
study does not demonstrate kombucha’s antibacterial properties. Moving forward, kombucha should 
still be considered as an antibacterial agent against enteric pathogens, such as S. typhimurium (ATCC 
13311). Based on the literature review and current study, we would recommend individuals to 
incorporate kombucha into their diet because of its beneficial effects on the gut microbiota and may be 
helpful to fight enteric infections. Future research should focus on whether or not kombucha has 
antibiotic-like effects in humans with enteric diseases. If this is established, then kombucha could 
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potentially be used as a substitute for antibiotics. Furthermore, we would suggest healthcare providers 
turn to fermented foods and beverages, like kombucha, which contain antibacterial properties as a first 
line in fighting infections. This would reduce the medical communities’ reliance on antibiotics, overall 
helping to control the spread of antibiotic-resistance. 
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